The Effect of the Educatıon and Counselıng of Prostatectomy Patıents


The research was planned as a randomized controlled experimental study. This study is planned to be conducted in the Urology clinic of a university hospital located in the south of Turkey. The population of the research will be the patients admitted to the urology clinic for prostatectomy. The sample of the study will consist of patients who meet the criteria for participation in the study and volunteer to participate in the study. Evaluation of the research data will be done with the SPSS package program.

Full Title of Study: “The Effect of educatıon and counselıng gıven to patıents patıent wıth Prostatectomy on qualıty of lıfe”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Supportive Care
    • Masking: Double (Investigator, Outcomes Assessor)
  • Study Primary Completion Date: October 25, 2022


  • Other: education
    • Oral and written education according to the life model

Arms, Groups and Cohorts

  • Experimental: experiment group
    • In addition to standard care, patients will be given discharge training, planned within the framework of the Life model, one day before discharge. It is planned that the discharge training will be given by the researcher in the patient’s room and by providing an accompanying person. Written training material will be delivered to the patients for their re-use after the training.
  • No Intervention: control group
    • standard care will be applied

Clinical Trial Outcome Measures

Primary Measures

  • Effect of traınıng and counselıng gıven after prostatectomy on qualıty of lıfe
    • Time Frame: six months
    • It will be measured with SF-12. Measurement will be made before and after the application. It is evaluated between 0 and 100 points, with a higher score representing better health.

Participating in This Clinical Trial

Inclusion Criteria

  • Being 18 years or older, – Being literate, – Being able to understand and speak Turkish and not have a hearing impairment, – Agreeing to participate in the research. Exclusion Criteria:

  • Development of any complications during the surgical intervention, – Having any psychiatric disorder that will reduce the ability to comprehend and understand, – Having other concomitant cancer, – Having metastases.

Gender Eligibility: All

Only male patients will be covered due to the surgical procedure.

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Cukurova University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sevgi Deniz Dogan, lecturer Dr. – Cukurova University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.